Attached files
| file | filename |
|---|---|
| EX-31.2 - AERI 3.31.2017 EX 31.2 - AERIE PHARMACEUTICALS INC | aeri3312017ex312.htm |
| 10-Q - AERI 3.31.17 10-Q - AERIE PHARMACEUTICALS INC | aerie33117.htm |
| EX-32.1 - AERI 3.31.2017 EX 32.1 - AERIE PHARMACEUTICALS INC | aeri3312017ex321.htm |
| EX-31.1 - AERI 3.31.2017 EX 31.1 - AERIE PHARMACEUTICALS INC | aeri3312017ex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the filing of the Quarterly Report on Form 10-Q of Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), for the period ended March 31, 2017 (the “Report”), the undersigned, Richard J. Rubino, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: May 3, 2017 | /s/ RICHARD J. RUBINO | |||
Richard J. Rubino | ||||
Chief Financial Officer | ||||
(Principal Financial and Accounting Officer) | ||||